Neurol. praxi. 2017;18(5):318-321 | DOI: 10.36290/neu.2017.131

T- lymphocytes and B-lymphocytes ant their role in multiple sclerosis

MUDr. Zuzana Matejčíková, Ph.D., prof. MUDr. Jan Mareš, Ph.D.
Neurologická klinika FN a LF UP Olomouc

The multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of central nervous system. The inflammatoryprocesses are present especially in early stages of MS. The neurodegenerative processes play role especially in later stages. Thereare characteristic inflammatory infiltrations (particularly in white matter) in MS. In these lesions are activating cells, ie. T-lymphocytes,macrophages and B- lymphocytes. Autoaggressive T and B lymphocytes have various functions in patogenesis of MS andplay any role in the demyelination of nerve fibers and damage of axons. The knowledge of their function is important for understandingthe MS and for development of the drugs modifying disease. In addition to autoimmune processes, the environmentalfactors (geographical, lifestyle, infections) have an important role in MS patogenesis.

Keywords: multiple sclerosis, T lymphocytes, B lymphocytes, autoimmune processes

Received: March 21, 2019; Accepted: April 23, 2019; Prepublished online: April 23, 2019; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Matejčíková Z, Mareš J. T- lymphocytes and B-lymphocytes ant their role in multiple sclerosis. Neurol. praxi. 2017;18(5):318-321. doi: 10.36290/neu.2017.131.
Download citation

References

  1. Ascherio A, Munger KL. EBV and autoimmunity. Curr. Top. Microbiol. Immunol. 2015; 390: 365-385 Go to original source... Go to PubMed...
  2. Baker D, Marta M, Pryce G, Giovannoni G, Schmierer K. Memory B. Cells are major targets for effective immunotherapy in relapsing multiple sclerosis. EBioMedicine 2017; 16: 41-50 Go to original source... Go to PubMed...
  3. Bednařík J, Ambler Z, Rôžička E, et al. Klinická neurologie. Část speciální I. Nakladatelství Triton. 2010: 510-512
  4. Blatt N, Khaiboullin T, Lombardi V, Rizvanov A, Khaiboullina S. The skin-brain connection hypothesis, bringing together CCL27-mediated T-cell activation in the skin and neural cell damage in the adult brain. Front. Immunol. 2017; 7: 683. Go to original source... Go to PubMed...
  5. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Böddeker I, Oertel WH, Sommer N, Hemmer B. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 2001; 124(Pt 11): 2169-2176. Go to original source... Go to PubMed...
  6. Giovannoni G, Ebers G. Multiple sclerosis: the environment and causation. Curr. Opin. Neurol. 2007; 20: 261-268. Go to original source... Go to PubMed...
  7. Havrdová E, Dušánková J, Gál O, Horáková D, Hoskovcová M, Kleinová P, Kovářová I, Krejsek J, Líbertínová J, Preiningerová J, Malinová R, Marečková H, Mareš J, Martásek P, Meluzínová E, Nytrová P, Piťha J, Suchá L, Štětkářová I, Taláb R, Tichá V, Vachová M, Vaněčková M, Zámečník L. Roztroušená skleróza. Mladá fronta 2013: 48-51.
  8. Hemmer B, Nessler S, Zhou D, Kieseier BC, Hartung HP. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol. 2006; 2(4): 201-11. Go to original source... Go to PubMed...
  9. Kieseier BC. Assessing long-term effects of disease modifying drugs. J Neurol 2006; 253: VI/23-VI/30. Go to original source...
  10. Krumbholz M, Derfuss T, Hohlfeld R, Meinl E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol. 2012; 8(11): 613-623. Go to original source... Go to PubMed...
  11. Martin R, Sopedra M, Rosito M, Engelhardt B. Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis. Eur. J. Immunol. 2016; 46: 2078-2090. Go to original source... Go to PubMed...
  12. Michel L, Touil H, Pikor NB, Gommerman JL, Prat A, Bar-Or A. B cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS - compartmentalized inflammation. Front. Immunol. 2015; 6: 636. Go to original source... Go to PubMed...
  13. Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, Magliozzi R, Reynolds R, Coccia EM, Aloisi F. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 2010; 69: 677-693. Go to original source... Go to PubMed...
  14. Sladkova V, Mares J, Lubenova B, Zapletalova J, Stejskal D, Hlustik P, Kanovsky P. Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome. Neurol Res. 2011; 33(4): 415-420. Go to original source... Go to PubMed...
  15. Wekerle H. B cells in multiple sclerosis. Autoimmunity, 2017; 50: 1, 57-60. Go to original source... Go to PubMed...
  16. Zouali M, Tsay G. Developing connections among B-Lymphocytes and deregulated pathways in autoimmunity. Molecular Medicine: 2016: 705-712. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.